iRhythm Holdings, Inc.
IRTC- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001388658
In the last 90 days, iRhythm Holdings, Inc. insiders filed 0 open-market purchases and 1 sale; 305 institutions reported holding it in 13F filings for Q2 2026, worth $4.24B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:47 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $44.6M (6.0% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 19, 2026 | Feb 20, 2025 | Feb 22, 2024 | Feb 23, 2023 | Feb 23, 2022 |
| Revenue | $747.1M | $591.8M | $492.7M | $410.9M | $322.8M |
| Cost of revenue | $219.9M | $184.3M | $160.9M | $129.3M | $109.3M |
| Gross profit | $527.3M | $407.5M | $331.8M | $281.6M | $213.6M |
| Operating expenses | $584.7M | $523.0M | $457.0M | $395.4M | $313.5M |
| Research and development | $84.6M | $71.5M | $60.2M | $46.6M | $38.7M |
| Selling, general and administrative | $492.6M | $418.6M | $385.6M | $322.2M | $274.8M |
| Operating income | -$57.4M | -$115.5M | -$125.2M | -$113.8M | -$99.9M |
| Interest expense | – | – | $3.65M | $4.14M | $1.17M |
| Income tax | $953.0K | $565.0K | $750.0K | $269.0K | $367.0K |
| Net income | -$44.6M | -$113.3M | -$123.4M | -$116.2M | -$101.4M |
| EPS, basic | $-1.39 | $-3.63 | $-4.04 | $-3.88 | $-3.46 |
| EPS, diluted | $-1.39 | $-3.63 | $-4.04 | $-3.88 | $-3.46 |
| Weighted shares, basic | 32.0M | 31.2M | 30.5M | 29.9M | 29.3M |
| Weighted shares, diluted | 32.0M | 31.2M | 30.5M | 29.9M | 29.3M |
| Margins and growth | |||||
| Gross margin | 70.6% | 68.9% | 67.3% | 68.5% | 66.2% |
| Operating margin | -7.7% | -19.5% | -25.4% | -27.7% | -31.0% |
| Net margin | -6.0% | -19.1% | -25.0% | -28.3% | -31.4% |
| Revenue growth, year over year | +26.2% | +20.1% | +19.9% | +27.3% | +21.7% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 19, 2026 | Feb 20, 2025 | Feb 22, 2024 | Feb 23, 2023 | Feb 23, 2022 |
| Cash and equivalents | $236.0M | $419.6M | $36.2M | $78.8M | $127.6M |
| Short-term investments | $347.8M | $116.0M | $97.6M | $134.3M | – |
| Accounts receivable | $75.7M | $79.9M | $61.5M | $49.9M | $46.4M |
| Inventory | $21.6M | $14.0M | $14.0M | $15.2M | $10.3M |
| Total current assets | $702.8M | $645.8M | $230.8M | $288.8M | $305.5M |
| Property, plant and equipment | $151.6M | $125.1M | $104.1M | $75.7M | $55.9M |
| Goodwill | $862.0K | $862.0K | $862.0K | $862.0K | $862.0K |
| Total assets | $1.02B | $931.4M | $433.1M | $448.2M | $463.0M |
| Accounts payable | $2.26M | $7.22M | $5.54M | $7.52M | $10.5M |
| Short-term debt | – | – | – | $0 | $11.7M |
| Total current liabilities | $151.9M | $110.9M | $107.4M | $89.1M | $87.9M |
| Long-term debt | – | – | $35.0M | $34.9M | $9.69M |
| Total liabilities | $867.3M | $840.5M | $223.0M | $208.4M | $183.5M |
| Shareholders' equity | $152.7M | $90.9M | $210.1M | $239.8M | $279.5M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 19, 2026 | Feb 20, 2025 | Feb 22, 2024 | Feb 23, 2023 | Feb 23, 2022 |
| Operating cash flow | $80.9M | $3.39M | -$50.1M | -$23.0M | -$37.8M |
| Capital expenditures | $46.3M | $33.9M | $40.4M | $29.8M | $28.1M |
| Free cash flow | $34.5M | -$30.6M | -$90.5M | -$52.8M | -$65.8M |
| Depreciation and amortization | $20.7M | $20.7M | $16.3M | $13.4M | $9.84M |
| Stock-based compensation | $88.3M | $76.0M | $77.2M | $57.7M | $54.5M |
| Share buybacks | $0 | $25.0M | – | – | – |
| Investing cash flow | -$277.1M | -$123.0M | -$1.21M | -$52.4M | $105.3M |
| Financing cash flow | $12.6M | $511.4M | $8.82M | $26.7M | -$28.6M |
| Net change in cash | -$183.6M | $391.8M | -$42.7M | -$48.7M | $38.9M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 11.8% | 12.8% | 15.7% | 14.1% | 16.9% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 29, 2026 | 33.6M | +4.3% | SEC |
| Jul 30, 2026 | 33.0M | +2.6% | SEC |
| Apr 23, 2026 | 32.9M | +2.9% | SEC |
| Feb 12, 2026 | 32.3M | +2.9% | SEC |
| Oct 23, 2025 | 32.2M | +2.9% | SEC |
| Jul 24, 2025 | 32.1M | +2.9% | SEC |
| Apr 24, 2025 | 31.9M | +2.6% | SEC |
| Feb 13, 2025 | 31.4M | +1.4% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.